Article info

Download PDFPDF
International Endocervical Adenocarcinoma Criteria and Classification (IECC): correlation with adverse clinicopathological features and patient outcome

Authors

  • Anjelica Hodgson Department of Laboratory Medicine and Molecular Diagnostics, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada PubMed articlesGoogle scholar articles
  • Ekaterina Olkhov-Mitsel Department of Laboratory Medicine and Molecular Diagnostics, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada PubMed articlesGoogle scholar articles
  • Brooke E Howitt Department of Pathology, Stanford University Medical Center, Stanford, California, USA PubMed articlesGoogle scholar articles
  • Marisa R Nucci Department of Pathology, Brigham and Women’s Hospital, Boston, Massachusetts, USA Department of Pathology, Harvard Medical School, Boston, Massachusetts, USA PubMed articlesGoogle scholar articles
  • Carlos Parra-Herran Department of Laboratory Medicine and Molecular Diagnostics, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Carlos Parra-Herran, Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON M4N3M5, Canada; carlos.parraherran{at}utoronto.ca
View Full Text

Citation

Hodgson A, Olkhov-Mitsel E, Howitt BE, et al
International Endocervical Adenocarcinoma Criteria and Classification (IECC): correlation with adverse clinicopathological features and patient outcome

Publication history

  • Received November 28, 2018
  • Revised January 2, 2019
  • Accepted January 3, 2019
  • First published January 24, 2019.
Online issue publication 
April 16, 2019

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.